Because of the impact of COVID-19 there is strain on research staff doing diabetes research in hospitals and GP surgeries across the UK. Using new trial methods, in which the trial coordinating office communicates directly with trial participants by telephone,… Read more

Type 2 diabetes is one of the most common chronic diseases in the UK. With ~3.9 million people with diabetes in the UK, as of 2019, the number is increasing. Type 2 diabetes is when an individual is unable… Read more

Diabetes (a condition where blood sugar level is too high) is associated with key complications such as cardiovascular, kidney, eye and foot conditions. However, people with diabetes may also be more likely to develop other conditions not necessarily flagged… Read more

There is increasing prevalence of diabetes, obesity, cardiovascular disease, and heart failure across most populations globally. The increase in diabetes includes both type 1 and type 2 diabetes. It is recognised by doctors that cardiovascular disease is commonly identified… Read more

This project aims to improve the design of clinical studies of intracerebral haemorrhage (ICH), a type of stroke caused by bleeding in the brain. It’s important that sufficient numbers of people take part in a… Read more

Heart and diabetes related problems are the number one cause of death in the world. Also known as cardiometabolic diseases, many of them are common and well-known. Some however are rare or found in less than 1 in 2,000 people. Read more

During the COVID-19 pandemic, healthcare providers had to quickly adapt their approach to screening, diagnosing, and managing high blood sugar levels in pregnancy, known as gestational diabetes (GDM). To minimise the risk of viral exposure, care providers made changes to… Read more

The medications called Sodium glucose co-transporter-2 inhibitors (SGLT2i) were developed as a diabetes drug but are now being used in people without diabetes who have heart failure or kidney disease.  In people with diabetes, infection with COVID-19 increases the risk… Read more